Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
van Slooten HJ, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard AM, Delobelle-Deroide A, van de Velde CJ, van de Vijver MJ. van Slooten HJ, et al. Among authors: mandard am. Br J Cancer. 1996 Jul;74(1):78-85. doi: 10.1038/bjc.1996.319. Br J Cancer. 1996. PMID: 8679463 Free PMC article. Clinical Trial.
Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
Mandard AM, Denoux Y, Herlin P, Duigou F, van De Vijver MJ, Clahsen PC, van Den Broek L, Sahmoud TM, Henry-Amar M, van De Velde CJ. Mandard AM, et al. Cancer. 2000 Oct 15;89(8):1748-57. doi: 10.1002/1097-0142(20001015)89:8<1748::aid-cncr15>3.0.co;2-e. Cancer. 2000. PMID: 11042570 Clinical Trial.
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
Raemaekers J, Burgers M, Henry-Amar M, Pinna A, Mandard A, Monfardini S, Hagenbeek A, Breed W, Carde P, Vovk M, van Hoof A, Thomas J, Noordijk E. Raemaekers J, et al. Ann Oncol. 1997;8 Suppl 1:111-4. Ann Oncol. 1997. PMID: 9187443 Clinical Trial.
Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases.
Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, de Ranieri E, Dupin P, Herlin P, de Ranieri J, Tanguy A, et al. Mandard AM, et al. Among authors: mandard jc. Cancer. 1989 Apr 1;63(7):1437-51. doi: 10.1002/1097-0142(19890401)63:7<1437::aid-cncr2820630735>3.0.co;2-q. Cancer. 1989. PMID: 2646010 Review.
Age at menarche as a prognostic factor in human breast cancer.
Juret P, Couette JE, Mandard AM, Carré A, Delozier T, Brune D, Vernhes JC. Juret P, et al. Among authors: mandard am. Eur J Cancer (1965). 1976 Sep;12(9):701-4. doi: 10.1016/0014-2964(76)90019-0. Eur J Cancer (1965). 1976. PMID: 971692 No abstract available.
Autopsy findings in 111 cases of esophageal cancer.
Mandard AM, Chasle J, Marnay J, Villedieu B, Bianco C, Roussel A, Elie H, Vernhes JC. Mandard AM, et al. Cancer. 1981 Jul 15;48(2):329-35. doi: 10.1002/1097-0142(19810715)48:2<329::aid-cncr2820480219>3.0.co;2-v. Cancer. 1981. PMID: 6453643
66 results